30 September 2023
: Case report 
Pimavanserin Treatment for Psychosis in Patients with Dementia with Lewy Bodies: A Case Series
Unusual or unexpected effect of treatment
Kasia Gustaw Rothenberg1ABDEF, Sharon G. McRae23BE, Liza M. Dominguez-Colman24BE, Andrew Shutes-David23DEF, Debby W. Tsuang24ABDE*DOI: 10.12659/AJCR.939806
Am J Case Rep 2023; 24:e939806
Table 3. Most recently used medications and responses.
| Patient # | Medications | Response |
|---|---|---|
| 1 | Sertraline and melatonin | Improved mood |
| Rivastigmine | Improved cognition | |
| Pimavanserin | Improved psychosis | |
| 2 | Clonazepam | Improved sleep induction |
| Rivastigmine | Minimally improved cognition | |
| Carbidopa/levodopa | Improved motor | |
| Paroxetine | Improved mood | |
| Pimavanserin | Improved psychosis | |
| 3 | Prazosin, quetiapine, and rivastigmine | Somewhat improved cognition and psychosis |
| 4 | Prazosin and melatonin | Improved nightmares |
| Donepezil | Mildly improved cognition | |
| Pimavanserin | Improved psychosis |